Cis-targeted IL-2 mutein to augment the anti-tumor activity of engineered T cells
{{output}}
Adoptively transferred T cells require cytokine stimulation, which is achieved using lymphodepleting chemotherapy with or without administration of exogenous interleukin 2 (IL-2). Lymphodepleting chemotherapy (LDC) is associated with cytopenias and attendant c... ...
